Sigyn Therapeutics (SIGY) Assets (2016 - 2025)

Sigyn Therapeutics has disclosed Assets across 10 years of filings, most recently posting $135571.0 for Q3 2025.

• In Q3 2025, Assets fell 68.28% year-over-year to $135571.0; the TTM figure through Sep 2025 stood at $135571.0 (down 68.28% YoY), while the FY2024 annual figure was $213719.0, down 33.59% from the prior year.
• Assets came in at $135571.0 for Q3 2025 at Sigyn Therapeutics, up from $51759.0 in the prior quarter.
• In the past five years, Assets ranged from a high of $2.0 million in Q2 2021 to a low of $51759.0 in Q2 2025.
• Average Assets over 5 years is $512559.2, with a median of $362273.0 recorded in 2022.
• Year-over-year, Assets surged 219.99% in 2021 and sank 83.83% in 2025.
• Over 5 years, Assets stood at $710259.0 in 2021, then sank by 53.13% to $332879.0 in 2022, then retreated by 3.33% to $321806.0 in 2023, then slumped by 33.59% to $213719.0 in 2024, then tumbled by 36.57% to $135571.0 in 2025.
• Per Business Quant data, the three most recent Assets figures were $135571.0 in Q3 2025, $51759.0 in Q2 2025, and $244309.0 in Q1 2025.